South Wales, July 17 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "ChelaBridge" on July 9. The details about the trademark application no. UK00004413668 published in the journal no. 2026/029 (July 17).
ChemKAS Pharmaceutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Reagents for use in the development of monoclonal antibodies [other than for medical or
veterinary purposes]; In-vivo radiological contrast substances for scientific use; Diagnostic
reagents for in-vitro use [other than medical]; In-vivo diagnostic reagents for scientific
use; Monoclonal antibody reagents, other than for medical use; Chemical components for
producing a radio-labelled monoclonal antibody for industrial or scientific use; Radiological
contrast substances, other than for medical purposes; Chemical reagents for use with
immunoassay analyzers, other than for medical or veterinary use; Diagnostic reagents for
in vitro use in biochemistry, clinical chemistry and microbiology; Gadolinium; Gallium
compounds; Diagnostic scanning agents for in-vivo use [other than medical]; Radioactive
preparations for laboratory purposes; Biochemicals, namely, monoclonal antibodies for in
vitro scientific or research use; Reagents for use with analyzers [other than for medical or
veterinary purposes]; Reagents for in-vitro laboratory use [other than for medical or
veterinary purposes]; Chemical preparations for use in the manufacture of
pharmaceuticals; Chemical substances for analyses in laboratories, other than for medical
or veterinary purposes; Diagnostic reagents and preparations, except for medical or
veterinary use; Reagents (Chemical -) other than for medical or veterinary
purposes; Immunoassay reagents, other than for medical use; Antibody reagents for
scientific purposes; Radiochemical products for scientific purposes; Chemical substances
for analysis in laboratories [other than for medical or veterinary purposes]; Chemical
reagents for use in biotechnology, other than for medical or veterinary use.
Class 5 : Radiopharmaceutical products; Diagnostic radiopharmaceutical
preparations; Pharmaceutical preparations and substances for use in
oncology; Pharmaceutical preparations for use in oncology; Injectable
pharmaceuticals; Pharmaceutical preparations for the treatment of tumours; Clinical
diagnostic reagents; Radioactive substances for medical purposes; Pharmaceutical
preparations for the prevention of tumours; Pharmaceutical preparations and substances
for the treatment of cancer; Pharmaceutical preparations for treating malignant
tumors; Pharmaceutical preparations and substances; Pharmaceuticals; Diagnostic
biomarker reagents for medical purposes; Clinical medical reagents; Pharmaceutical
preparations for the treatment of bone diseases; Pharmaceutical preparations for
suppressing tumors; Pharmaceutical preparations and substances for the prevention of
cancer; Medical diagnostic reagents; Radio-isotope markers for therapeutic or diagnostic
use; Pharmaceutical products for the treatment of bone diseases; Cardiovascular
pharmaceuticals; Diagnostic reagents for medicinal use; Pharmaceutical drugs; Antitumor
drugs; Synthetic peptides for pharmaceutical purposes.
Class 42 : Development of pharmaceutical preparations and medicines; Laboratory services relating
to the production of monoclonal antibodies; Research and development of vaccines and
medicines.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004413668
Disclaimer: Curated by HT Syndication.
